Proteases

Items 401-450 of 1361

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. NS5B polymerase inhibitor

    ABT-072 is a nonnucleoside NS5B polymerase inhibitor and a candidate drug evaluated for treatment of hepatitis C virus.
  2. calcineurin (CN) inhibitor

    Voclosporin is a calcineurin (CN) inhibitor.
  3. FT011 is an anti-fibrotic agent, reduces mRNA expression of collagens I and III and inhibits collagen synthesis.
  4. proteasome subunit Rpn11 inhibitor

    Rpn11-IN-1 (Capzimin intermediate) is a potent and selective inhibitor of proteasome subunit Rpn11 with an IC50 of 390 nM.
  5. caspase inhibitor

    Biotin-VAD-FMK is a cell permeable, irreversible biotin-labeled caspase inhibitor, used to identify active caspases in cell lysates.
  6. Apaf-1 inhibitor

    ZYZ-488 is a competitive apoptotic protease activating factor-1 (Apaf-1) inhibitor, which inhibits the activation of binding protein procaspase-9 and procaspase-3.
  7. FABP4 inhibitor

    LDN 0088050 is selectivity adipocyte fatty acid binding protein (AFABP, FABP4) inhibitor with Ki values of 0.29 and 1.3 μM for FABP4 and FABP3, respectively. LDN 0088050 binds to FABP4 with a Kd of 2.05 μM.
  8. HIV-1 reverse transcriptase inhibitor

    beta-L-D4A is a nucleoside HIV-1 reverse transcriptase inhibitor.
  9. synthetic thrombin inhibitor

    OM-189 is a selective synthetic thrombin inhibitor.
  10. Imazamox (CL29926) is a systemic herbicide that inhibits the production of acetolactate synthase (ALS) in plants with high selectivity, high activity, safety and broadspectrum activity, which would then inhibit plant growth and ultimately lead to plant death.
  11. human neutrophil elastase inhibitor

    Lodelaben is a human neutrophil elastase inhibitor with an IC50 and Ki of 0.5 and 1.5 μM, respectively.
  12. uPA system inhibitor

    UKI-1 is a novel synthetic inhibitor of the urokinase-type plasminogen activator system.
  13. PGAM1 inhibitor

    PGMI-004A is a potent phosphoglycerate mutase 1 (PGAM1) inhibitor with an IC50 of 13.1 μM.
  14. Aldose reductase inhibitor

    Sorbinil, is an Aldose reductase inhibitor (ARI).
  15. HCV polymerase inhibitor

    JTK-853 is a novel, non-nucleoside Hepatitis C Virus (HCV) polymerase inhibitor which shows effective antiviral activity in HCV replicon cells with EC50s of 0.38 and 0.035 ?M in genotype 1a H77 and 1b Con1 strains, respectively.
  16. HNE inhibitor

    BAY-85-8501 is a selective, reversible and potent inhibitor of Human Neutrophil Elastase (HNE), with an IC50 of 65 pM.
  17. MMP inhibitor

    BR351 precursor is a precursor of BR351. BR351 is a brain penetrant MMP inhibitor with IC50s of 4, 2, 11, 50 nM for MMP2, MMP8, MMP9 and MMP13, respectively.
  18. anti-secretagogue of PCSK9

    R-IMPP is an anti-secretagogue of PCSK9 (IC50=4.8 μM), which targets the 80S ribosome to inhibit PCSK9 protein translation.
  19. NEP inhibitor

    Candoxatril is a neutral endopeptidase (NEP) inhibitor.
  20. NS4A antagonist

    ACH-806 is an NS4A antagonist which can inhibit Hepatitis C Virus (HCV) replication with an EC50 of 14 nM.
  21. MMP inhibitor

    XL-784 is a selective matrix metalloproteinases (MMP) inhibitor, with IC50s of ~1900, 0.81, 120, 10.8, 18, 0.56 nM for MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-13 respectively.
  22. MMP inhibitor

    PNU-248686A is a novel matrix metalloproteinase (MMP) inhibitor.
  23. human neutrophil elastase inhibitor

    AE-3763 is a peptide-based human neutrophil elastase inhibitor with an IC50 of 29 nM.
  24. HIV protease inhibitor

    DPC-681 is a potent and selective inhibitor of HIV protease with IC90s for wild-type HIV-1 of 4 to 40 nM.
  25. chymotrypsin inhibitor

    FK-448 Free base is an effective and specific inhibitor of chymotrypsin, with an IC50 of 720 nM.
  26. NQO2 inhibitor

    Dabigatran ethyl ester hydrochloride is a potent inhibitor of ribosyldihydronicotinamide dehydrogenase (NQO2) with an IC50 value of 0.8 μM and a thrombin inhibitor.
  27. serine protease inhibitor

    Nafamostat is an anticoagulant. Broad spectrum serine protease inhibitor. Reduces eosinophil infiltration, mast cell activation and airway responsiveness in a murine model of asthma.
  28. serine protease inhibitor

    Nafamostat hydrochloride is an anticoagulant. Broad spectrum serine protease inhibitor. Reduces eosinophil infiltration, mast cell activation and airway responsiveness in a murine model of asthma.
  29. HIV protease inhibitor

    Darunavir is an HIV protease inhibitor
  30. ITPKA inhibitor

    BAMB-4(ITPKA-IN-C14) is a new membrane-permeable inhibitor against inositol-1,4,5-trisphosphate-3-kinase A((ITPKA) with IC50 of 37 μM in ADP-Glo Assay.
  31. SHIP-2 inhibitor

    AS1949490 is a potent and selective SHIP-2 (SH2 domain-containing inositol 5?? phosphatase 2) inhibitor, with an IC50 of 620 nM. AS1949490 activated glucose metabolism via up-regulation of GLUT1 gene in L6 myotubes.
  32. aldose reductase inhibitor

    Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes.
  33. NEP inhibitor

    Sacubitrilat is an active neprilysin (NEP) inhibitor.
  34. LYP inhibitor

    LTV-1 is a highly potent, cell-permeable and reversible inhibitor of lymphoid tyrosine phosphatase (LYP) (IC50 = 508 nM).
  35. D77

    anti-HIV-1 inhibitor

    D77 is anti-HIV-1 inhibitor targeting the interaction between integrase and cellular LEDGF/p75.
  36. HCV NS3/4a protein inhibitor

    HCV-IN-3 is a hepatitis C virus (HCV) NS3/4a protein inhibitor, with an IC50 of 20 μM, a Kd of 29 μM.
  37. aldose reductase inhibitor

    Aldose reductase-IN-1 is a inhibitor of aldose reductase with IC50 of 28.9 pM. IC50 value: 28.9 pM Target: aldose reductase Detailed information please refer to WO2014113380 A1 and US20130225592.
  38. Heparin is a highly sulfated glycosaminoglycan,that is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule.
  39. serine protease inhibitor

    Upamostat is a serine protease inhibitor. Upamostat is the orally available prodrug of the WX-UK1, which is a urokinase plasminogen activator (uPA) inhibitor.
  40. cysteine protease inhibitor

    Cysteine Protease inhibitor is an inhibitor of cysteine protease.
  41. ACE/NEP inhibitor

    Omapatrilat is a dual inhibitor of the metalloproteases ACE and NEP with Ki values of 0.64 and 0.45 nM, respectively.
  42. cathepsin inhibitor

    VBY-825 is a novel, reversible cathepsin inhibitor with high potency against cathepsins B, L, S and V.
  43. PKK inhibitor

    Avoralstat is an oral plasma kallikrein (PKK) inhibitor, used for the treatment of hereditary angioedema.
  44. aldose reductase inhibitor

    Risarestat (CT-112), an aldose reductase inhibitor, is developed for the treatment of diabetic complications
  45. Phenoxodiol, a synthetic analog of Genestein, activates the mitochondrial caspase system, inhibits XIAP (an apoptosis inhibitor), and sensitizes the cancer cells to Fas-mediated apoptosis.
  46. gamma secretase inhibitor

    BMS-906024 is an oral and selective gamma secretase inhibitor (GSI) that is a small molecule Notch inhibitor.
  47. HCV nucleotide inhibitor

    PSI-352938 (PSI-938) is a hepatitis C virus (HCV) nucleotide inhibitor.
  48. DPP4 inhibitor

    Gemigliptin is a highly selective dipeptidyl peptidase 4 (DPP4) inhibitor with a KD of 7.25 nM.
  49. γ-secretase inhibitor

    Compound E is a γ-secretase inhibitor.
  50. PPP1R15B inhibitor

    Raphin1 acetate is an orally bioavailable, selective inhibitor of the regulatory phosphatase PPP1R15B (R15B).

Items 401-450 of 1361

Page
per page
Set Descending Direction